Anders, Hans-Joachim
Jayne, David R. W.
Rovin, Brad H.
Article History
First Online: 25 January 2016
Competing interests
: H.-J.A. has received consultancy fees from GlaxoSmithKine, Roche and Bayer. D.R.W.J. has received research grants from Roche/Genentech and Sanofi/Genzyme, consultancy fees from Boehringer-Ingelheim, BIOGEN, Chemocentryx, GlaxoSmithKine and Roche/Genentech, and is a director of Aurinia Pharmaceuticals Inc. B.H.R. has received consultancy fees from Genentech, Biogen, Roche, Boehringer-Ingelheim, Lilly, and Mallinckrodt, and a research grant from Mallinckrodt.